Publication | Open Access

Single-Agent Pemetrexed for Chemonaïve and Pretreated Patients with Malignant Pleural Mesothelioma: Results of an International Expanded Access Program

Surgical OncologyOncologyMalignant Pleural MesotheliomaPleural DiseaseSingle-agent PemetrexedMedicineRadiation Oncology